Relating to prohibiting the use or sale of abortifacients
West Virginia bill prohibits manufacturing, selling, and using medications that terminate pregnancy, restricting pharmaceutical abortion access statewide.
West Virginia bill prohibits manufacturing, selling, and using medications that terminate pregnancy, restricting pharmaceutical abortion access statewide.
HB 2461 proposes to prohibit the use or sale of abortifacients—medications or substances intended to terminate pregnancy—in West Virginia. The bill was recently introduced and is currently under review by the House Health and Human Resources Committee. The measure represents an expansion of abortion restrictions beyond surgical procedures to include pharmaceutical abortion methods.
Abortifacients, particularly mifepristone (used in medication abortion), account for the majority of abortions in the United States. Restricting access directly affects reproductive healthcare options available to West Virginia residents and could influence prescribing practices for medications with multiple uses (such as misoprostol). The bill's passage could significantly reshape abortion access in the state and potentially impact telemedicine abortion services.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.